Drew, Richard

Azole antifungals: 35 years of invasive fungal infection management

Allen, D., Wilson, D., Drew, R., & Perfect, J. (2015) · Expert Review of Anti-infective Therapy

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 255

Ceftriaxone Once Daily for Four Weeks Compared with Ceftriaxone Plus Gentamicin Once Daily for Two Weeks for Treatment of Endocarditis Due to Penicillin-Susceptible Streptococci

Sexton, D. J., Tenenbaum, M. J., Wilson, W. R., Steckelberg, J. M., Tice, A. D., Gilbert, D., Dismukes, W., Drew, R. H., Durack, D. T., & Endocarditis Treatment Consortium Group (1998) · Clinical Infectious Diseases

Infective Endocarditis Diagnosis and ManagementStreptococcal Infections and Treatments

Cited by 195

Cost of invasive fungal infections in the era of new diagnostics and expanded treatment options

Ashley, E. D., Drew, R., Johnson, M., Danna, R., Dabrowski, D., Walker, V., Prasad, M., Alexander, B., Papadopoulos, G., & Perfect, J. (2012) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 62

Echinocandins: Addressing outstanding questions surrounding treatment of invasive fungal infections

Holt, S. L., & Drew, R. H. (2011) · American Journal of Health-System Pharmacy

Antifungal resistance and susceptibilityOcular Infections and Treatments

Cited by 26

Electronic health record-based readmission risk model performance for patients undergoing outpatient parenteral antibiotic therapy (OPAT)

Drew, R., Brenneman, E., Funaro, J., Lee, H.-J., Yarrington, M., Dicks, K., & Gallagher, D. (2023) · PLOS Digital Health

Machine Learning in HealthcareHospital Admissions and Outcomes

Cited by 5